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AIM
The recent success in the treatment of head and neck squamous cell car-
cinoma with checkpoint inhibitors has stimulated researchers in the under-
standing of the role that the immune system plays in cancer. The immune 
system interacts intimately with tumors over the entire process of disease 
development and progression to metastasis. Recently, Chen and Mellman 
classified cancer in relation to the immune system, distinguishing three phe-
notypes: Inflamed, Immune-escaped and Immune-desert1. In this paper, we 
analyzed tongue squamous cell carcinoma (TSCC) samples, according to 
the aforementioned classification, in order to study the role of the immune 
system in this subtype of tumors.
MATERIALS AND METHODS
In this study, 82 patients surgically treated for SCCTs at the Department 
of Maxillofacial Surgery, “Ospedali Riuniti” General Hospital (Ancona, Italy), 
between 2011 and 2016 were included. Clinical and radiologic data were 
obtained from each patient’s medical record, and pathologic data were 
retrieved from the archives of the Sections of Pathology, Marche Polytechnic 
University, Italy. Tumors were classified on the basis of the immune infiltrated 
in: Inflamed, Immune-escaped and Immune-desert; and correlated with clinic 
pathological parameters.




Pathological analysis of immune-phenotype of TSCC samples revealed that: 
59.8% (49/82) were classified as Inflamed, 30.5% (25/82) as Immune-Excluded 
and 9.8% (8/82) as Immune-desert. In addition, the ratio carcinoma stroma in 
TSCC inversely correlated with the size of the tumor at the time of diagnosis. 
DISCUSSION
The analysis of the immune-phenotype could be used to further stratify 
patients with TSCC2. A possible inclusion of this parameter in the clinical 
staging needs to be evaluated in further well-standardized studies3.
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